Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

In English

Författare

  • Kiran Musunuru
  • Alanna Strong
  • Maria Frank-Kamenetsky
  • Noemi E. Lee
  • Tim Ahfeldt
  • Katherine V. Sachs
  • Xiaoyu Li
  • Hui Li
  • Nicolas Kuperwasser
  • Vera M. Ruda
  • James P. Pirruccello
  • Brian Muchmore
  • Ludmila Prokunina-Olsson
  • Jennifer L. Hall
  • Eric E. Schadt
  • Carlos R. Morales
  • Sissel Lund-Katz
  • Michael C. Phillips
  • Jamie Wong
  • William Cantley
  • Timothy Racie
  • Kenechi G. Ejebe
  • Marju Orho-Melander
  • Olle Melander
  • Victor Koteliansky
  • Kevin Fitzgerald
  • Ronald M. Krauss
  • Chad A. Cowan
  • Sekar Kathiresan
  • Daniel J. Rader
Visa allt

Summary, in English

Recent genome-wide association studies (GWASs) have identified a locus on chromosome 1p13 strongly associated with both plasma low-density lipoprotein cholesterol (LDL-C) and myocardial infarction (MI) in humans. Here we show through a series of studies in human cohorts and human-derived hepatocytes that a common noncoding polymorphism at the 1p13 locus, rs12740374, creates a C/EBP (CCAAT/enhancer binding protein) transcription factor binding site and alters the hepatic expression of the SORT1 gene. With small interfering RNA (siRNA) knockdown and viral overexpression in mouse liver, we demonstrate that Sort1 alters plasma LDL-C and very low-density lipoprotein (VLDL) particle levels by modulating hepatic VLDL secretion. Thus, we provide functional evidence for a novel regulatory pathway for lipoprotein metabolism and suggest that modulation of this pathway may alter risk for MI in humans. We also demonstrate that common noncoding DNA variants identified by GWASs can directly contribute to clinical phenotypes.

Publiceringsår

2010

Språk

Engelska

Sidor

2-714

Publikation/Tidskrift/Serie

Nature

Volym

466

Issue

7307

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Cardiac and Cardiovascular Systems
  • Endocrinology and Diabetes

Status

Published

Forskningsgrupp

  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Hypertension

ISBN/ISSN/Övrigt

  • ISSN: 0028-0836